{"name": "Mirna Therapeutics",
 "permalink": "mirna-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/mirna-therapeutics",
 "homepage_url": "http://www.mirnatherapeutics.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2007,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@mirnatherapeutics.com",
 "phone_number": "512-901-0900 ",
 "description": "",
 "created_at": "Thu Dec 17 14:31:43 UTC 2009",
 "updated_at": "Mon Mar 25 18:02:17 UTC 2013",
 "overview": "\u003Cp\u003EMirna Therapeutics, Inc. (Mirna) is a discovery-stage biopharmaceutical research and development company focused on miRNA-directed human oncology therapies. Featuring world-class research capabilities, a strong understanding of miRNA and cancer biology, and an expansive IP portfolio, Mirna Therapeutics is well-positioned to capitalize on the emerging field of miRNA-based therapeutics.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       34],
      "assets/images/resized/0007/0130/70130v1-max-150x150.jpg"],
     [[250,
       58],
      "assets/images/resized/0007/0130/70130v1-max-250x250.jpg"],
     [[254,
       59],
      "assets/images/resized/0007/0130/70130v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Chairman",
    "person":
     {"first_name": "Matt",
      "last_name": "Winkler",
      "permalink": "matt-winkler",
      "image": null}},
   {"is_past": false,
    "title": "President \u0026 CEO",
    "person":
     {"first_name": "Paul",
      "last_name": "Lammers",
      "permalink": "paul-lammers",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$41M",
 "funding_rounds":
  [{"round_code": "grant",
    "source_url": "https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32\u0026aid=DJFVW00020091215e5cg00105\u0026r=Rss\u0026s=DJFVW",
    "source_description": "Mirna Therapeutics Taps Texas For $5M, Bulks Up Board  ",
    "raised_amount": 5000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 12,
    "funded_day": 16,
    "investments":
     []},
   {"round_code": "unattributed",
    "source_url": "http://www.finsmes.com/2011/08/mirna-therapeutics-closes-1-5m-equity-financing.html?utm_source=feedburner\u0026utm_medium=feed\u0026utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29",
    "source_description": "Mirna Therapeutics Closes $1.5M Equity Financing Round",
    "raised_amount": 1500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 8,
    "funded_day": 23,
    "investments":
     []},
   {"round_code": "c",
    "source_url": "http://www.finsmes.com/2012/10/mirna-therapeutics-completes-34-5m-series-financing.html",
    "source_description": "Mirna Therapeutics Completes $34.5M Series C Financing",
    "raised_amount": 34500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 10,
    "funded_day": 24,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Sofinnova Ventures",
         "permalink": "sofinnova-ventures",
         "image":
          {"available_sizes":
            [[[150,
               26],
              "assets/images/resized/0003/0428/30428v1-max-150x150.jpg"],
             [[194,
               34],
              "assets/images/resized/0003/0428/30428v1-max-250x250.jpg"],
             [[194,
               34],
              "assets/images/resized/0003/0428/30428v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "New Enterprise Associates",
         "permalink": "new-enterprise-associates",
         "image":
          {"available_sizes":
            [[[150,
               110],
              "assets/images/resized/0001/5083/15083v3-max-150x150.png"],
             [[150,
               110],
              "assets/images/resized/0001/5083/15083v3-max-250x250.png"],
             [[150,
               110],
              "assets/images/resized/0001/5083/15083v3-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Pfizer Venture Investments",
         "permalink": "pfizer-venture-investments",
         "image":
          {"available_sizes":
            [[[150,
               97],
              "assets/images/resized/0025/2881/252881v1-max-150x150.png"],
             [[200,
               130],
              "assets/images/resized/0025/2881/252881v1-max-250x250.png"],
             [[200,
               130],
              "assets/images/resized/0025/2881/252881v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Osage University Partners",
         "permalink": "osage-university-partners",
         "image":
          {"available_sizes":
            [[[139,
               67],
              "assets/images/resized/0012/4232/124232v5-max-150x150.png"],
             [[139,
               67],
              "assets/images/resized/0012/4232/124232v5-max-250x250.png"],
             [[139,
               67],
              "assets/images/resized/0012/4232/124232v5-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Correlation Ventures",
         "permalink": "correlation-ventures",
         "image":
          {"available_sizes":
            [[[150,
               41],
              "assets/images/resized/0017/0256/170256v1-max-150x150.png"],
             [[250,
               68],
              "assets/images/resized/0017/0256/170256v1-max-250x250.png"],
             [[277,
               76],
              "assets/images/resized/0017/0256/170256v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "2150 Woodward St",
    "address2": "Suite 1000",
    "zip_code": "78744",
    "city": "Austin",
    "state_code": "TX",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        82],
       "assets/images/resized/0007/0129/70129v1-max-150x150.jpg"],
      [[250,
        137],
       "assets/images/resized/0007/0129/70129v1-max-250x250.jpg"],
      [[450,
        246],
       "assets/images/resized/0007/0129/70129v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}